New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine
Drug Testing and Analysis · 2023-04 · 15 (4) · 426-443
DOI: 10.1002/dta.3430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 03.01.2023. Verfasst von Andrea E Steuer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Sodium Oxybate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Gamma‐hydroxybutyric acid (GHB) represents an important drug in clinical and forensic toxicology, particularly in the context of drug‐facilitated crimes. Analytically, GHB remains a major challenge given its endogenous occurrence and short detection window. Previous studies identified a number of potential interesting novel conjugates of GHB with carnitine, amino acids (AA, glutamate, glycine, and taurine), or fatty acids. As a basis for comprehensive studies on the suitability of these novel biomarkers, we developed and validated a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method in human urine. Additionally, already known markers 2,4‐dihydroxy butyric acid (2,4‐DHB), 3,4‐DHB, glycolic acid, succinic acid, succinylcarnitine, and GHB glucuronide were included. The method was fully validated according to (inter)national guidelines. Synthetic urine proved suitable as a surrogate matrix for calibration. Matrix effects were observed for all analytes with suppression effects of about 50% at QC LOW, and approximately 20% to 40% at QC HIGH, but with consistent standard deviation of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
- Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.
ORCID-Profile: Andrea E Steuer, Christian Steuer, Thomas Kraemer
Zitieren
APA
Steuer, A. E., Sutter, L., Steuer, C., & Kraemer, T. (2023). New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine. Drug Testing and Analysis, 15(4), 426-443. https://doi.org/10.1002/dta.3430
Vancouver
Steuer AE, Sutter L, Steuer C, Kraemer T. New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine. Drug Testing and Analysis. 2023;15(4):426-443. doi:10.1002/dta.3430
BibTeX
@article{Steuer2023,
author = {Steuer, Andrea E and Sutter, Linda and Steuer, Christian and Kraemer, Thomas},
title = {New gamma‐hydroxybutyric acid (GHB) biomarkers: Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of GHB amino acid, carnitine, and fatty acid conjugates in urine},
journal = {Drug Testing and Analysis},
year = {2023},
volume = {15},
number = {4},
pages = {426--443},
doi = {10.1002/dta.3430}
}
EUVIMED